Skip to main content
TipRanks
Go Ultimate75% OFF

TScan Therapeutics (TCRX) Cash flow

430 Followers

TScan Therapeutics Cash Flow

TCRX's free cash flow for Q3 2026 was $-27.12M. For the 2026 fiscal year, TCRX's free cash flow was decreased by $-41.00K and operating cash flow was $-27.08M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -135.32M$ -110.82M$ -61.36M$ -66.50M$ -48.68M
$ 109.37M$ -52.61M$ -60.76M$ -4.22M$ -9.94M
$ -336.00K$ 208.76M$ 135.44M$ 29.36M$ 189.67M
$ 157.44M$ 183.72M$ 138.39M$ 125.06M$ 166.44M
$ -139.73M$ -114.65M$ -64.50M$ -70.73M$ -58.62M

Currency in USD

TScan Therapeutics Cash Flow

-200M-100M0100M200M300M2019202020212022202320242025OperatingInvestingFinancing